L-selectin mediates the initial tethering and subsequent rolling of leucocytes along luminal walls of inflamed venules. TACE [TNFα (tumour necrosis factor α)-converting enzyme] is responsible for cleaving the membrane-proximal extracellular domain of Lselectin (also known as shedding), which reduces the efficiency of leucocyte recruitment to sites of inflammation. Many reports have highlighted roles for PKC (protein kinase C) and p38 MAPK (mitogen-activated protein kinase) in promoting L-selectin shedding with little insight into the mechanism involved. By using PMA and the phosphatase inhibitors cantharidin and calyculin A, we could selectively activate PKC or p38 MAPK respectively to promote TACE-dependent shedding of L-selectin. Interestingly, the intracellular mechanisms leading to the shedding event differed dramatically. For example, regulatory elements within the L-selectin cytoplasmic tail, such as ERM (ezrin/radixin/moesin)-binding and serine residues, were important for PKC-but not p38 MAPK-dependent shedding. Also, increased and sustained cell surface levels of TACE, and phosphorylation of its cytoplasmic tail (a hallmark of TACE activation), occurred in lymphocytes and monocytes following p38 MAPK activation. Finally, we showed that TNFα-induced shedding of L-selectin in monocytes was strikingly similar to cantharidin-induced shedding and suggest that this newly characterized mechanism could be physiologically relevant in inflammatory cells.
INTRODUCTION
L-selectin is a cell adhesion molecule that mediates the initial capture and subsequent rolling of leucocytes along endothelial cell-expressed ligands that line the luminal wall of post-capillary venules [1, 2] . Leucocyte trafficking is strongly dependent on the expression levels of cell adhesion molecules on both leucocytes and endothelial cells [3] . Surface levels of L-selectin can be modulated at the transcriptional level [4] or post-translationally via ectodomain shedding [5] , for example in response to TNFα (tumour necrosis factor α) or LPS (lipopolysaccharide) challenge [6, 7] . The protease that mediates shedding of L-selectin is TACE [TNFα-converting enzyme; also known as ADAM17 (a disintegrin and metalloproteinase 17)] [8] , and studies using leucocytes and fibroblasts devoid of TACE activity (by virtue of a mutation engineered within the zinc-binding domain, termed TACE Zn/ Zn ) reveal a role for this sheddase in both activationdependent and basal shedding [9, 10] . The biological significance of L-selectin shedding is not well understood, but previous studies have revealed a role in regulating the rolling velocity of neutrophils [5] as well as redirecting the traffic of antigenactivated effector memory T-cells away from lymph nodes [11] . Furthermore, significant levels of soluble L-selectin are present in the plasma of healthy mice and humans (between 1.5 and 2 μg/ml) [12, 13] , which increases significantly under certain disease states [14, 15] . Therefore the presence of higher levels of soluble L-selectin in the circulation could potentially hinder leucocyte recruitment by reducing ligand availability for cellassociated L-selectin. Finally, shedding of L-selectin can be very rapid (within minutes), providing a potential mechanism to downregulate signalling through L-selectin during adhesion.
The use of artificial inducers of L-selectin shedding, such as PMA, has contributed significantly to our understanding of the molecular basis underlying shedding [16] . PMA directly activates PKC (protein kinase C) isoenzymes, which have been shown to phosphorylate serine residues in the L-selectin tail [17, 18] . Other inducers of L-selectin shedding, which include hypertonic stress [19] , intracellular acidification [20] and mechanical shedding of L-selectin (i.e. the loss of L-selectin during neutrophil rolling) [21] have all been shown to be p38 MAPK (mitogenactivated protein kinase)-dependent. However, the intracellular mechanisms that lead to shedding are poorly understood. In the light of this, understanding how PKCs and p38 MAPK contribute to L-selectin shedding became the main focus of the present study. Using cantharidin and PMA to selectively activate p38 MAPK and PKC respectively, we show that TACE-dependent shedding of L-selectin occurs via different signalling pathways. This suggests that shedding can occur via two distinct mechanisms. Our findings are of particular importance to understanding how L-selectin is shed in response to diverse outside-in signals, for example during neutrophil rolling [21] or during T-cell receptor activation [18] .
The murine 300.19 pre-B-cell line, stably expressing WT (wildtype) and R357A forms of human L-selectin have been described previously [22] . Stable 300.19 pre-B-cell lines expressing sheddase-resistant ( M-N) and cytoplasmic serine-mutated forms of L-selectin were generated and cultured as previously described for R357A cells [22] . These cells were grown in RPMI 1640 medium containing L-glutamine (Invitrogen) supplemented with 10 % (v/v) FCS (fetal calf serum), 1 % (v/v) of 100 units/ml penicillin and streptomycin, 50 μM 2-mercaptoethanol and 2 μg/ml puromycin. Cells were maintained at 37
• C with 5 % CO 2 under humidifying conditions and seeded overnight at a density of 0.5 × 10 6 cells/ml before each experiment. Peripheral blood leucocytes were isolated from human peripheral blood collected from healthy volunteer donors. Studies were carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association and was approved by the local ethics committee. Written informed consent was obtained from all donors. Diluted blood in 25 ml of neat or modified HBSS (Hanks balanced salt solution) (Invitrogen) was layered on 15 ml of Histopaque-1077 in sterile 50 ml Falcon tubes and sedimented by centrifugation for 30 min at room temperature (25 • C) (with no break). Mononucleated cells were aspirated from a buffy coat layer and washed three times in modified HBSS. The erythrocyte/neutrophil-containing 'pellet' was resuspended in modified HBSS (1:1) and then diluted with sterile filtered 2 % Dextran-500 (Amersham Biosciences) in modified HBSS (1:1). The erythrocytes were allowed to sediment for 20 min at room temperature before the upper, neutrophil-containing, layer was collected, diluted in modified HBSS and harvested by centrifugation. The cell pellet was then resuspended in 3 ml of sterile water for 30 s to lyse remaining red blood cells. After lysis, the suspension was diluted to 50 ml with modified HBSS and centrifuged at 250 g for 5 min with a low break. Neutrophil and mononuclear cell pellets were resuspended in 10 % (v/v) FCS in HBSS supplemented with 25 mM Hepes, counted and used immediately.
MEFs (mouse embryonic fibroblasts) derived from WT or TACE Zn/ Zn murine embryos (a gift from Professor Roy Black, Amgen, Seattle, WA, U.S.A.) were maintained in RPMI 1640 medium containing L-glutamine supplemented with 10 % (v/v) FCS plus 1 % (v/v) of 100 units/ml penicillin and streptomycin. These cells have been described in detail previously [23] .
Antibodies and plasmids
The murine anti-(human L-selectin) antibody, DREG56, which recognizes the lectin domain, was purified from the HB-300 hybridoma. A mouse IgG 1 isotype control antibody was obtained from Santa Cruz Biotechnology. Rabbit anti-mouse immunoglobulin F(ab ) 2 conjugated to RPE [R-PE (phycoerythrin)] (Dako) was used as a secondary antibody for DREG56 or an isotype control antibody. PE-conjugated DREG56 (DREG56-PE) and isotype control antibodies were purchased from Santa Cruz Biotechnology. Mouse IgG 2a -FITC isotype control and mouse anti-(human CD11a)-FITC antibodies were both obtained from Serotec. An antibody recognizing the cytosolic portion of TACE (Clone C15 sc-6410) was used for immunoprecipitation and Western blotting (Santa Cruz Biotechnology). Anti-moesin clone C-15 sc-6416 (Santa Cruz Biotechnology), anti-p38, anti-phospho-p38 (which recognizes phospho-Thr 180 /Tyr 182 ), anti-MAPK substrate (anti-phospho-threonine-proline) and anti-phospho-ERM (ezrin/radixin/moesin) (Cell Signaling Technology) antibodies were used for Western blotting. Anti-(human TACE ectodomain) antibody was obtained from R&D Systems. Goat anti-rabbit and rabbit anti-goat horseradish-peroxidaseconjugated secondary antibodies were purchased from Dako. For Western blotting of immunoprecipitated proteins, anti-rabbit Trueblot TM secondary antibodies (eBioscience), which preferentially recognize the non-reduced primary antibody rather than the reduced immunoprecipitating antibody, were used where possible.
Expression vectors for WT and R357A human L-selectin were described previously [22] . M-N and serine mutants of L-selectin were generated using standard mutagenesis techniques as instructed by Stratagene's QuikChange ® XL II kit. Briefly, the cDNA of WT human L-selectin was amplified by PCR from a plasmid containing the cDNA of WT human L-selectin (Origene) into the pMT2 vector. Subsequently, complementary primers were designed to exclude codons for Met 325 -Asn 332 . Resultant plasmids were sequenced to verify successful deletion/substitution of amino acids within the L-selectin tail.
L-selectin and LFA-1 (lymphocyte function-associated antigen 1) shedding assays Approx. 5 × 10 5 -1 × 10 6 cells were treated in 200 μl of medium (10 % FCS in HBSS with 25 mM Hepes or growth medium for leucocytes/U937s and 300.19/MEF cells respectively) supplemented with PMA, cantharidin, calyculin A, phosphatidic acid, human TNFα (R&D systems), LPS (Invitrogen) or equivalent amounts of the appropriate carrier at 37
• C and 5% CO 2 for 30 min. Any inhibitor pre-treatment was also carried out at 37
• C and 5% CO 2 for 30 min but in 100 μl of medium before another 100 μl of 2 × concentrated solutions of the desired stimulus (PMA, cantharidin, etc.) was added for another 30 min. The stimulation solutions also contained the appropriate inhibitor to maintain the concentration upon dilution of the cell suspension. Inhibitors used were: 100 μM Ro-31-9790 (metalloproteinase inhibitor); pan-PKC inhibitor Ro-31-8220 (5 μM); p38 inhibitor, SB202190 (25 μM); and MEK [MAPK/ERK (extracellularsignal-regulated kinase) kinase] inhibitor, PD98059 (50 μM). Cell-surface L-selectin or LFA-1 expression was then determined by flow cytometry.
Flow cytometric analysis
Cells were labelled with antibody on ice for 30 min. All washes were performed using 10 % (v/v) FCS in HBSS with 25 
ELISA for soluble L-selectin
An aliquot of 500 μl of 300.19 cells expressing WT human L-selectin resuspended in 1 % BSA in RPMI at a density of 5 × 10 5 cells/ml were left untreated or treated with 1 nM, 10 nM, 100 nM or 1 μM PMA, 100 μM, 250 μM, 500 μM or 1mM cantharidin or 20 nM, 40 nM or 80 nM calyculin A for 30 min at 37
• C and 5% CO 2 . Cell-free supernatants were then obtained by centrifugation at 18 200 g for 5 min at 4
• C. Equal volumes (100 μl) of cell-free supernatant from each sample were assayed for the presence of soluble L-selectin using a commercially available ELISA kit (R&D Systems). All samples were performed in triplicate. Soluble Lselectin levels were determined by comparison with a standard curve created using known quantities of soluble L-selectin standards. All standards were run in duplicate and the mean value was used for each experiment.
Immunoprecipitation
For the immunoprecipitation of TACE, approx. 0.5-1 × 10 8 U937 cells were harvested by centrifugation at 310 g after stimulation in 10 ml of growth medium for 30 min at 37
• C and 5% CO 2 (with or without prior incubation of SB202190 for 30 min). The pellet was subsequently lysed in 1 ml of ice-cold lysis buffer [1 % Nonidet P40, 20 mM Tris/HCl, pH 8, 150 mM NaCl, 10 mM NaF, protease inhibitor cocktail (Roche), 0.1 mM Na 3 VO 4 , 1 mM PMSF and 4 mM EDTA] supplemented with 25 nM calyculin A on ice for 15 min (note that calyculin A was supplemented into the lysis buffer to prevent dephosphorylation of endogenous ERMs after stimulation). Lysates were clarified by centrifugation at 18 200 g and 4
• C for 10 min. A small fraction of the lysate was retained for a loading control, whereas the remaining lysate was pre-cleared with 25 μl of pre-equilibrated Protein G-agarose beads (Santa Cruz Biotechnology) at 4
• C under continuous agitation for 1 h. The beads were pelleted by centrifugation at 18 200 g for 5 min at 4
• C, and the lysate was transferred to a fresh tube containing 5 μg of anti-(TACE cytoplasmic domain) antibody, or an unrelated isotype matched control (goat polyclonal anti-moesin), before the addition of 25 μl of pre-equilibrated Protein G-agarose beads followed by an incubation for a further 2 h (under continuous agitation at 4
• C). The immunoprecipitate was washed once in lysis buffer supplemented with calyculin A (1 ml) and then a further three times with lysis buffer. Proteins bound to the beads were solubilized by boiling in protein sample buffer (100 mM Tris/HCl, pH 6.8, 4 % SDS, 10 % glycerol, 0.2 % Bromophenol Blue and 1.8 % 2-mercaptoethanol).
Immunoblotting
This procedure was conducted as previously described [24] . In brief, cells were stimulated in 1 ml of growth medium at a density of 5 × 10 6 cells/ml for 30 min at 37
• C and 5% CO 2 . Cells were subsequently lysed and the equivalent of approx. 1 × 10 6 cells were resolved in each lane. All primary antibodies were used at 1:1000 as per manufacturers' instructions and all secondary antibodies were used at 1:5000.
Transfection of U937s and MEFs
Microporation was performed using a Digital Bio in-tip electroporation apparatus. Cells were grown in antibiotic-free medium for at least 24 h before microporation to increase viability and transfection efficiency. For microporation of MEFs, cells were seeded the previous day at 70 % confluency and harvested using trypsin-EDTA, centrifed at 250 g and washed once in PBS. Transfection was performed as instructed by the manufacturers. Cells (10 6 ) in 10 μl were transfected with 2 μg of WT or M-N L-selectin plasmid. Each 10 μl electroporation was placed into a separate well of a six-well plate containing 2 ml of antibioticfree medium and allowed to recover overnight. All transfected cells were pooled in to a single population prior to each shedding assay to ensure that a single equivalent population of cells was used for each treatment. Trypsinization of MEFs had no effect on L-selectin expression (results not shown).
RESULTS

Inhibition of serine/threonine phosphatases induces the rapid loss of cell-surface-associated L-selectin
The role of serine/threonine phosphatases in regulating the shedding of L-selectin has never been addressed before. We therefore sought to determine whether inhibition of phosphatases could lead to L-selectin shedding. Cantharidin is a natural compound derived from the blister beetle and has been used in a study to elicit the in vivo migration of leucocytes from human blood to skin blisters [25] . Cantharidin is known to inhibit the PP1 (protein phosphatase 1)/PP2A family of phosphatases [26] . Interestingly, a previous study has shown that ectodomain shedding of the integrin αLβ2 (LFA-1) and L-selectin occurs in blister-resident neutrophils and monocytes [25] . However, the study never determined whether the effect was due to direct exposure to cantharidin [25, 27] . To this end, freshly isolated primary leucocytes were challenged with increasing doses of cantharidin for 30 min. The dose of cantharidin required to induce skin blisters was calculated to be approx. 4 mM [25] . Therefore doses below 2 mM were used to determine the direct effect of cantharidin on L-selectin expression. It should be noted that cantharidin was poorly soluble in DMSO, which resulted in high working concentrations. The doses of cantharidin used within a 30 min time scale was non-toxic as replenishing cells in normal growth medium after stimulation Western blots were developed in seconds by exposure to X-ray film. Over-exposure (1 min) of PVDF membrane to X-ray film reveals that ERMs are phosphorylated in response to 100 μM cantharidin. Moesin the most abundant ERM in leucocytes, was probed as a loading control. All experiments were performed at least three times in triplicate.
did not result in cell death (see Supplementary Figure S1 at http://www.BiochemJ.org/bj/428/bj4280293add.htm).
Flow cytometric analysis revealed a dose-dependent reduction in surface L-selectin in response to increasing concentrations of cantharidin ( Figures 1A-1C) . In contrast, cell-surface levels of LFA-1 remained relatively unchanged in response to cantharidin stimulation ( Figures 1A-1C ). These results suggest that direct exposure of primary leucocytes to cantharidin results in the potent loss of L-selectin but not LFA-1 expression. Cantharidin treatment also led to a dose-dependent loss in L-selectin expression in murine 300.19 pre-B-cells stably expressing human L-selectin (see Supplementary Figure S1 ). Finally, the use of an alternative PP1/PP2A inhibitor, calyculin A, produced similar results (see Supplementary Figure S1 ), suggesting that phosphatase inhibitors can dramatically affect L-selectin expression levels. Interestingly, the concentration range of calyculin A used to induce the loss in L-selectin expression was close to concentrations known to inhibit phosphatase activity (i.e. between 10 and 40 nM, see Supplementary Figure S1I ).
Further evidence for the phosphatase inhibitory effects of cantharidin was demonstrated by analysing C-terminal phosphorylation of ERM. Treatment of lymphocytes with calyculin A has been shown to induce rapid C-terminal phosphorylation of ERM proteins [28] , which is a hallmark of ERM activation [29] . Replacing calyculin A with cantharidin (100-500 μM) also led to a marked increase in C-terminal phosphorylation of ERM in 300.19 pre-B-lymphocytes ( Figure 1D ), which was concordant with the loss of L-selectin expression (compare results in Figure 1D with results in Supplementary Figure S1 ). On the basis of this approach, it was apparent that phosphatase inhibition could be achieved using cantharidin concentrations ranging between 100 and 500 μM. This concentration range was therefore used in subsequent studies to effectively inhibit phosphatase activity. Collectively, these results confirm that inhibition of serine/threonine phosphatases promotes the rapid loss of cell-surface-expressed L-selectin, which implies that such phosphatases are constitutively active in resting leucocytes and probably act, in part, to negatively regulate shedding.
Cantharidin-induced loss of L-selectin expression is mediated by a metalloproteinase activity
Antigen-capture ELISA was next used to determine whether the loss of surface-expressed L-selectin in response to phosphatase inhibition was due to the release of soluble L-selectin. Stimulation of 300.19 pre-B-cells stably expressing WT L-selectin with increasing doses of PMA, calyculin A or cantharidin led to a dose-dependent increase in the liberation of soluble L-selectin ( Figure 2A) . Interestingly, the levels of soluble L-selectin liberated into the cell-free supernatant was independent of the stimulus used, suggesting that the extent of shedding was comparable.
Shedding of L-selectin is known to occur via TACE, which can be inhibited by the zinc-dependent metalloproteinase inhibitor Ro-31-9790 [30] . To verify that cantharidin-induced loss of L-selectin expression occurs via the action of a metalloproteinase, 300.19 pre-B-cells stably expressing WT L-selectin were pre-incubated with 100 μM Ro-31-9790 for 30 min prior to stimulation with cantharidin. Pre-treatment with Ro-31-9790 markedly reduced the extent to which Lselectin was down-regulated in response to PMA, calyculin A or cantharidin stimulation (see Supplementary Figure S2 at http://www.BiochemJ.org/bj/428/bj4280293add.htm). Shedding of L-selectin occurs at a defined extracellular membrane-proximal domain that is located approximately ten amino acids from the plasma membrane [31] . To confirm further that the shedding of Lselectin occurs at the known cleavage site, 300.19 pre-B-cell lines stably expressing either WT L-selectin or a sheddase-resistant form of L-selectin ( M-N) were subjected to either cantharidin or PMA stimulation. M-N has been characterized in previous studies and was demonstrated to effectively inhibit PMA-induced shedding [32] . As expected, WT L-selectin was efficiently shed in response to challenge with either stimulus (Figures 2B and  2C ). In contrast, neither cantharidin nor PMA could induce shedding in cell lines expressing M-N L-selectin, suggesting that correct positioning of the L-selectin cleavage site is critical for cantharidin-induced shedding ( Figures 2B and 2C) . Moreover, our results exclude the possibility that cantharidin-induced loss of Lselectin expression could be due to internalization or microparticle release. Collectively, these results strongly imply that cantharidin induces bona fide shedding of L-selectin, and suggests that the mechanism of cleavage may be similar to PMA-induced shedding of L-selectin.
Cantharidin-induced shedding of L-selectin is TACE-dependent
Attempts to knock down TACE using siRNA (small interfering RNA) has proved to be challenging in suspension cell lines (for example in U937 promonocytic cells; D.J. Killock and A. Ivetić, unpublished work). In addition, Ro-31-9790 is known to inhibit other metalloproteinases besides TACE. We therefore used TACE Zn/ Zn MEFs as an alternative approach to determine the specificity of the metalloproteinase responsible for cantharidininduced shedding of L-selectin. Indeed, transfection of L-selectin in MEFs has been used in previous studies to monitor differences between basal and activation-induced shedding of L-selectin [9] . Mammalian expression vectors harbouring the open reading frames of either WT or M-N human L-selectin were microporated into WT or TACE Zn/ Zn MEFs, and subsequently challenged with either PMA or cantharidin. Shedding of WT L-selectin was dramatically suppressed when TACE Zn/ Zn MEFs were challenged with cantharidin, and similar outcomes were observed in response to PMA stimulation (see Supplementary Figure  S3 at http://www.BiochemJ.org/bj/428/bj4280293add.htm). As expected, no shedding was observed in either WT or TACE Zn/ Zn MEFs expressing M-N L-selectin (see Supplementary Figure  S3 ). Conversely, cantharidin and PMA stimulation led to the concomitant shedding of WT L-selectin only in WT MEFs, further highlighting a role for TACE in cantharidin-induced shedding of L-selectin.
Cantharidin-induced shedding occurs independently of L-selectin-ERM interaction
The results of the present study so far show strong observational parallels between PMA-induced shedding and cantharidininduced shedding, suggesting that both processes could be mechanistically similar. The cytoplasmic tail of L-selectin has been shown to be important in regulating PMA-induced shedding. For example, we have previously shown that abrogating L-selectin/ERM interaction results in reduced PMA-induced shedding of L-selectin [22] . To assign a putative role for L-selectin/ERM interaction in cantharidin-induced shedding, 300.19 pre-B-cells stably expressing either WT L-selectin, or an ERM-binding mutant of L-selectin called R357A, were challenged with increasing concentrations of either PMA or cantharidin. As anticipated, shedding of R357A L-selectin was markedly reduced following PMA stimulation ( Figure 3A) . Surprisingly, treatment with cantharidin resulted in shedding of . Stable cell lines expressing non-phosphorylatable, or phospho-mimicking, mutants of L-selectin were challenged with increasing doses of either PMA (D and E) or cantharidin (F). Levels of L-selectin were measured using flow cytometry, and remaining L-selectin levels were expressed as a percentage of untreated controls (i.e. carrier alone). Statistical significance for serine mutant forms of L-selectin in comparison with WT at the same concentration of stimulus was determined by unpaired Student's t test; *P 0.05, **P 0.01 and ***P 0.001. All experiments were performed at least three times in triplicate.
R357A L-selectin that was indistinguishable from WT L-selectin ( Figure 3B ). This result suggests that L-selectin/ERM interaction is dispensable for cantharidin-induced shedding.
Mutation of serine residues in the L-selectin tail affects PMA-but not cantharidin-induced shedding
The cytoplasmic tail of human L-selectin has two serine residues at positions 364 and 367 (Ser 364 and Ser 367 , see Figure 3C ). Previous reports have shown that these residues become phosphorylated in response to either PMA or T-cell receptor stimulation [17, 18] , suggesting that they may play a role in regulating shedding. We therefore explored whether Ser 364 and Ser 367 were required for regulating cantharidinor PMA-induced shedding. Stable cell lines were generated in 300.19 pre-B-cells to express either non-phosphorylatable alanine mutants or phospho-mimicking aspartate mutants of Lselectin (see Supplementary Figure S4 at http://www.BiochemJ. Neutrophils, PBLs and monocytes were isolated from fresh whole blood and pre-incubated with an inhibitor targeting p38 MAPK (SB202190), PKC isoenzymes (Ro-31-8220) or MEK/ERK (PD98059) in order to assign the involvement of a specific family of kinases involved in regulating PMA-(A-C) or cantharidin-(D-F) induced shedding. This study used 100 nM PMA and 500 μM cantharidin. Statistical significance was calculated between carrier-and inhibitor-treated cells by unpaired Student's t test; *P 0.05, **P 0.01, ***P 0.001. All experiments were performed at least three times in triplicate.
org/bj/428/bj4280293add.htm). Each cell line was subjected to increasing amounts of PMA or cantharidin, and surface levels of L-selectin were monitored by flow cytometry. Significant changes in the expression levels of L-selectin were seen in all cell lines as a consequence of PMA stimulation ( Figures 3D and 3E ). Of particular interest was the finding that PMA-induced shedding of S367A L-selectin had reduced, and, in contrast, shedding of S367D L-selectin had increased ( Figure 3E ). Interestingly, we found that mutation of Ser 364 to either alanine or aspartate resulted in reduced shedding of L-selectin ( Figure 3D ). These results suggest more complex roles for the serine residues in regulating PMA-induced shedding, and/or that substitution mutagenesis of serine to aspartate at position 364 does not necessarily mimic phosphorylation. Antigen-capture ELISA revealed that the basal turnover of WT and mutant L-selectins displayed no significant differences from one another (see Supplementary Figure S5 at http://www.BiochemJ.org/bj/428/bj4280293add.htm).
Curiously, the extent of L-selectin shedding induced by cantharidin in all the cell lines tested did not deviate from the shedding of WT L-selectin ( Figure 3F ). However, a similar trend in increased loss of S367D L-selectin in response to middling doses of cantharidin was observed, but this was not statistically significant. Stimulation with calyculin A also promoted normal shedding in all cell lines tested, suggesting that this mode of shedding was not dependent on regulatory elements within the Lselectin tail (see Supplementary Figure S5 ). In summary, these results suggest that serine residues in the L-selectin tail play a central role in regulating PMA-induced shedding, but are redundant for cantharidin-or calyculin A-induced shedding.
Cantharidin-induced shedding of L-selectin is p38 MAPK-dependent
Both PKC and MAPK isoenzymes have been implicated in mediating signals that lead to shedding of L-selectin [19, 21, 33] . For example, p38 MAPK regulates shedding of L-selectin in response to osmotic cell stress and mechanical shedding [19, 21] , and PKC-dependent shedding of L-selectin has been shown to occur in response to stimulation of the T-cell receptor [18] . A range of kinase inhibitors were therefore used to target PKCs (Ro-31-8220) and the MAPKs p38 MAPK (SB202190) and MEK1 (PD98059), an upstream activator of ERK. Primary lymphocytes, neutrophils and monocytes were isolated from whole blood and pre-incubated with each kinase inhibitor prior to stimulation with either PMA or cantharidin. As expected, PMA-induced shedding was almost completely blocked by Ro-31-8220 in all primary leucocytes tested ( Figures 4A-4C ). In contrast, SB202190 and PD98059 had little effect on PMA-induced shedding. Moreover, the extent of L-selectin shedding increased beyond 100 % in all leucocytes pre-treated with SB202190 (see the second bar of each histogram in Figures 4A-4C ). This implies that inhibition of p38 MAPK could lead to increased accumulation of L-selectin at the cell surface by preventing the basal turnover of Lselectin at the plasma membrane. Cantharidin-induced shedding remained unaffected by Ro-31-8220 pre-treatment, suggesting that PKCs are not involved in mediating the shedding response ( Figures 4D-4F) . However, cantharidin-induced shedding was strongly inhibited by SB202190, but not PD98059, implying that p38 MAPK, and not MEK/ERK, plays an important role in this pathway (Figures 4D-4F ). (A and B) or cantharidin (Canth; C and D) for the indicated time points. Cells were lysed, resolved on polyacrylamide gels and transferred on to PVDF membranes for Western blotting. Immunoblots were probed with either a phospho-specific anti-(p38 MAPK) antibody (p-p38), or an anti-p38 antibody to monitor total p38 levels from whole-cell lysates. (E) The relative activity of p38 MAPK was monitored by Western blot analysis following stimulation of U937 cells with 100 nM PMA or 500 μM cantharidin. Total TACE levels were monitored by Western blotting to determine whether any gross changes at the protein level were seen following stimulation. The relative levels of β-actin served as loading control. All experiments were performed at least three times.
To test this further, anti-phospho-p38 MAPK antibody (which recognizes the phosphorylation of both Thr 180 and Tyr 182 ) was used to probe Western blots of whole-cell lysates of neutrophils and PBMCs (peripheral blood mononuclear cells) that had been stimulated with either PMA or cantharidin over time ( Figure 5 ). Interestingly, PMA stimulation affected p38 MAPK phosphorylation differently in neutrophils and PBMCs (compare Figure 5A with Figure 5B ). Phospho-p38 MAPK levels rose rapidly in response to PMA stimulation, whereas no increase was seen in neutrophils, suggesting cell-type variation. This increase in phospho-p38 MAPK levels had no effect on the shedding of L-selectin, as this could not be blocked with SB202190 ( Figures 4B and 4C) , suggesting a p38 MAPKindependent mechanism. In contrast, phosphorylation of p38 MAPK in response to cantharidin stimulation was delayed in both neutrophils and PBMCs ( Figures 5C and 5D) . As PBMCs contain a mixture of PBLs and monocytes, we tested responses of the monocytic U937 cell line to PMA and cantharidin stimulation. As with neutrophils, no increase in phospho-p38 MAPK was observed following PMA stimulation. However, a significant and delayed increase in phospho-p38 MAPK was observed following cantharidin, which was similar to the other cell types tested ( Figure 5E ). No gross changes in total TACE levels in U937 cells was observed, as judged by Western blotting, suggesting that stimulation by either PMA or cantharidin has no effect on TACE at the protein level ( Figure 5E ).
Cantharidin induces sustained surface expression and cytoplasmic tail phosphorylation of TACE via p38 MAPK
Based on the tail-dependent and tail-independent mechanisms of L-selectin shedding observed in response to respective PMA and cantharidin stimulation, we next sought to determine whether TACE itself was regulated differently in response to cantharidin and PMA. Mobilization of TACE to the plasma membrane is deemed a hallmark of TACE maturation [34, 35] . To this end, flow cytometry was used to monitor the surface levels of Lselectin and TACE in PBLs and monocytes over a 60 min time course of PMA and cantharidin stimulation (Figures 6A-6D ). Irrespective of cell type, shedding of L-selectin occurred more rapidly in response to PMA than cantharidin treatment (i.e. 5 min compared with 15 min respectively; see Figure 6A -6D). Interestingly, L-selectin shedding and surface expression of TACE appeared to be inversely correlated, suggesting a possible causal link between the two events ( Figures 6A and 6B ), although this was less apparent in monocytes ( Figures 6C and 6D) . Furthermore, PMA stimulation led to transient increases in TACE expression ( Figures 6A and 6C) , whereas cantharidin stimulation resulted in continued and sustained surface expression of TACE ( Figures 6B and 6D ). Increased and sustained expression of TACE was also observed in U937 cells following cantharidin but not PMA stimulation (see Supplementary Figure S7 at http://www.BiochemJ.org/bj/428/bj4280293add.htm). We next determined whether blocking p38 MAPK activity would have an Values were recorded as percentages of expression levels relative to untreated controls. All experiments were performed at least three times in triplicate. (E) U937 cells, primary neutrophils, monocytes and PBLs were pre-incubated with or without SB202190 prior to treatment with 500 μM cantharidin for 30 min at 37 • C. Surface levels of TACE were monitored using flow cytometry as in previous experiments. All statistical evaluations were performed using an unpaired Student's t test; # P 0.05, **/ ## P 0.01 and ***/ ### P 0.001. '*' indicates statistical significance comparing carrier with cantharidin treatment (in the absence of SB202190) and '#' indicates statistical significance comparing treatments with and without pre-incubation of SB202190.
effect on surface levels of TACE expression following cantharidin stimulation. Indeed, in all cases, TACE mobilization to the plasma membrane was blocked in cells pre-treated with SB202190, implying the importance of p38 MAPK in regulating the traffic of TACE to the plasma membrane.
Previous reports have highlighted a role for MEK/ERK in targeting threonine residues within the cytoplasmic tail of TACE [34, 35] . Threonine phosphorylation of the TACE cytoplasmic tail has since been interpreted as a hallmark of its activity. In an attempt to determine whether the TACE cytoplasmic tail was threonine-phosphorylated in response to either PMA or cantharidin stimulation, TACE was immunoprecipitated from lysates of U937 cells that were pre-treated with either stimulus over various time points. No threonine phosphorylation of the TACE cytoplasmic tail was detected in immunoprecipitates derived from lysates of PMA-stimulated U937 cells ( Figure 7A,  lanes 1 and 2) . On the other hand, TACE cytoplasmic tail phosphorylation was detected at low levels in cantharidin-treated U937 cells at 30 min and more robustly at 60 min, which is concordant with when TACE surface expression was greatest and when L-selectin surface expression was lowest ( Figure 7A,  lanes 5-9) . Collectively, these observations further highlight mechanistic differences between cantharidin-and PMA-induced shedding. Interestingly, phosphorylation of the cytoplasmic tail of TACE was blocked if cells were pre-treated with SB202190. This implies that p38 could be involved in directly phosphorylating the tail of TACE, although further experiments are required to verify this.
TNFα-induced shedding of L-selectin is mechanistically similar to cantharidin-induced shedding
We next sought to determine whether our findings were physiologically relevant. TNFα has previously been shown to induce the shedding of L-selectin in neutrophils [6] . It is also known that p38 MAPK participates in signalling downstream of TNF receptor stimulation. Indeed, Western blotting of lysates derived from TNFα-treated PBMCs and neutrophils showed increased phospho-p38 MAPK levels ( Figure 8A ). Interestingly, pre-treatment of monocytes and neutrophils with SB202190 led to a marked suppression of TNFα-induced shedding of L-selectin ( Figures 8B and 8C) , suggesting that p38 MAPK was involved in mediating the shedding response. A modest, but statistically significant, level of PKC activity was also involved in the shedding response in monocytes, suggesting cell-type variation and possible redundancies between the kinases ( Figure 8C) . However, the effect of blocking p38 MAPK activity was far more robust, suggesting a greater involvement of p38 MAPK in the shedding response. No increase in the expression of TACE was seen in neutrophils as a consequence of TNFα stimulation. This was rather unexpected, but one explanation could be due to increased turnover of active TACE at the plasma membrane, which has been previously described in another cell type [34] . However, increased and sustained expression of TACE was observed in monocytes challenged with TNFα ( Figure 8D ), which was similar to what had been observed in response to cantharidin stimulation ( Figure 6D ), but not PMA stimulation ( Figure 6C) . Moreover, surface expression of TACE was concordant with Immunoprecipitates were resolved on polyacrylamide gels and subsequently transferred on to PVDF membranes. The same antibody that was used to immunoprecipitate TACE was used to probe for TACE (top blot). Anti-phospho-threonine (Phospho-ThrPro) antibody was used to determine whether the cytoplasmic tail of TACE was threonine phosphorylated in response to cantharidin treatment (bottom blot). WB, Western blot. L-selectin shedding, which ensued at approx. 15 min ( Figure 8D ). Finally, pre-treatment of monocytes with SB202190 led to a marked reduction in surface expression of TACE following stimulation with TNFα ( Figure 8E ). Taken together, these results imply that TNFα-induced shedding of L-selectin could be driven by mechanisms akin to cantharidin-induced shedding rather than PMA-induced shedding. Finally, we further confirmed that LPS-induced p38 MAPK activation in monocytes led to an increased and sustained expression of TACE, and was concordant with L-selectin shedding (see Supplementary Figure S8 at http://www.BiochemJ.org/bj/428/bj4280293add.htm).
DISCUSSION
The present paper is the first to describe two divergent mechanisms for L-selectin shedding that are guided differently by PKC and p38 MAPK. Activation of p38 MAPK through the use of phosphatase inhibitors leads to threonine phosphorylation of the TACE cytoplasmic tail, and increased and sustained expression of TACE at the plasma membrane. Furthermore, ERM binding and serine residues of the L-selectin tail are redundant in this mechanism. Paradoxically, selective activation of PKC by PMA requires ERM binding and serine residues in the L-selectin tail to mediate shedding. Phosphorylation of the TACE cytoplasmic tail and increased sustained expression of TACE at the plasma membrane were not observed in response to PMA stimulation.
The role of p38 MAPK in regulating L-selectin shedding has been previously explored in a couple of reports [19, 21] , but the intracellular mechanism regulating this has been poorly defined. It is possible that the mechanism postulated in the present report could apply to other p38 MAPK-dependent mechanisms of L-selectin shedding, although this will require further investigation. What is clear from the present study is that threonine phosphorylation of the TACE cytoplasmic tail and mobilization of TACE to the plasma membrane is p38 MAPK-dependent. A proposed model for p38 MAPK-dependent shedding of L-selectin is shown in Supplementary Figure S9 (at http://www.BiochemJ.org/bj/428/bj4280293add.htm). It is noteworthy that the cytoplasmic tail of TACE has previously been shown to be phosphorylated by ERK at Thr 735 [34, 35] . This has been shown to increase maturation and surface expression of TACE [34] . Interestingly, the amino acids surrounding Thr 735 (PQTP) provide a highly conserved p38 MAPK phosphorylation motif. It is therefore likely that p38 MAPK and ERK target a similar site in TACE, which may be stimulus-dependent or celltype-dependent. It is believed that phosphorylation of Thr 735 is the only motif within the TACE tail that can be recognized by the anti-MAPK substrate (anti-phospho-threonine-proline) antibody [35] . It is also interesting to note that the turnover of TACE at the plasma membrane differed over time between PMA and cantharidin stimulation, which may reflect how p38 MAPK and PKC regulate the membrane traffic of TACE ( Figure 6 ). During the writing of the present paper, work by Wang et al. [36] described a redundant role for the cytoplasmic tail of TACE in PMA-induced shedding of L-selectin. This further corroborates the results of the present study to suggest that the cytoplasmic tail of TACE is regulated by p38 MAPK, but not PKC activityhighlighting divergent mechanisms in TACE-dependent shedding of L-selectin.
It is tempting to speculate that the difference in surface expression of TACE could be partly dictated by changes in the cortical actin-based cytoskeleton. For example, we and others [28] have observed an early (5 min) increase in ERM activation following cantharidin stimulation (see Figure 1D ), which is in stark contrast with the early inactivation of ERM in response to PMA stimulation (A. Ivetić and D.J. Killock, unpublished work). Net increases in ERM activity has been linked to increased cortical cellular rigidity [37] , which may play a role in restricting vesicular traffic to and from the plasma membrane. As such, cantharidin stimulation may lead to the sustained expression of TACE at the plasma membrane, whereas PMA stimulation could lead to reduced plasma membrane rigidity to restrict the transient traffic of TACE to the plasma membrane within a short period of time. Determining whether the cortical actin cytoskeleton plays a role in the turnover of TACE at the leucocyte plasma membrane will be the focus of future studies.
Our current work has highlighted a central role for Ser 364 and Ser 367 in regulating PMA-but not cantharidin-induced shedding. The outcome of shedding from the various L-selectin mutants was not easily predictable, particularly for the Ser 364 mutants. For example, shedding of S364A L-selectin in response to PMA stimulation was much reduced compared with WT Lselectin. Strangely, shedding of S364D L-selectin in response to PMA stimulation was also much reduced. Our results could be interpreted in at least two different ways: (i) the S364D mutant does not act as a phospho-mimicking mutant, but behaves more like a non-phosphorylatable mutant; or (ii) phosphorylation of L-selectin at position Ser 364 may require a subsequent dephosphorylation step to complete the shedding process effectively.
In contrast with the Ser 364 mutants, S367A and S367D mutants of L-selectin were respectively resistant and sensitized to PMAinduced shedding. It is possible that phosphorylation of Ser 367 could influence phosphorylation/dephosphorylation of Ser 364 by kinases/phosphatases. Although a previous study identified a number of PKC isoenzymes that bind to and phosphorylate L-selectin at Ser 364 and Ser 367 [18] , it would be necessary to determine whether interaction with such kinases occurs in vivo. Microscopy techniques using FRET (fluorescence resonance energy transfer) have recently been employed in determining Lselectin-binding partner interaction [38] , which could potentially address this issue in intact cells. In addition, identification of a phosphatase that could potentially dephosphorylate the tail of L-selectin at Ser 364 would be required to determine whether a dephosphorylation step is synonymous with resolving PMAinduced shedding.
In summary, we have identified two distinct mechanisms by which L-selectin can be cleaved by TACE. In each case, the cytoplasmic tails of TACE and L-selectin are involved in promoting either p38 MAPK-or PKC-dependent shedding respectively. How these kinases might be involved in regulating L-selectin-dependent trafficking within the innate and acquired immune system will be an interesting focus for further study.
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David Killock performed all of the experiments, and contributed to experimental design and the writing of the manuscript. Aleksandar Ivetić designed and directed the project, assisted in some of the experiments (for Figures 2 and 3) , and wrote the manuscript. . This suggests that cantharidin is not toxic to the cells during the course of the experiment. Similar results were obtained using calyculin A (I), with no change to the scatter profile (not shown). In contrast, exposure of 300.19 cells to phosphatidic acid (a PP1-specific inhibitor) did not affect shedding of L-selectin (H), but induced massive cell death at the highest dose (100 μM; compare F with G). Note that the upper region of interest is known as the 'dead gate', which represents dying cells as they become more granular and enter apoptosis. All readings for L-selectin levels (in E and H) were measured from the lower region of interest (or live gate). Relative expression levels were compared with 300.19 cells treated with DMSO carrier for 30 min. These results are the sum of three independent experiments. LFA-1 levels were too low to monitor in this cell line and were therefore excluded from the analysis. Shedding of L-selectin was considered to be specific in response to cantharidin treatment as stimulation of 300. Cell-free supernatants from 0.5 × 10 6 300.19 pre-B-cells were analysed over a 6 h time course using ELISA as outlined in the Experimental section of the main paper. These results provide conclusive evidence that the turnover of L-selectin is not dramatically affected by incorporating a single amino acid exchange mutations made at either Ser 364 or Ser 367 .
SUPPLEMENTARY ONLINE
Figure S6 Calyculin A induces shedding of mutant L-selectin, which paradoxically resists PMA-induced shedding
Cells stably expressing serine to alanine or serine to aspartate mutations at either position 364 or 367 were stimulated for 30 min at 37 • C with varying concentrations of calyculin A. Cells were monitored for surface levels of L-selectin using flow cytometry and compared with cells treated with carrier alone (i.e. DMSO). Along with the results presented in Figure 4 (F) in the main paper, these results highlight a redundant role for serine residues in promoting the shedding of L-selectin via inhibition of PP1/PP2A. Calyculin A is more readily soluble in DMSO than cantharidin, which is why effects on shedding are observed to be closer to the predicted working range for inhibiting phosphatases (i.e. 20-40 nM). This experiment was performed at least three times in triplicate.
Figure S7 Surface levels of TACE in U937 cells increases in response to cantharidin but not PMA stimulation U937 cells were treated with or without stimulus (i.e. DMSO control) and were incubated at 37 • C for up to 60 min. Using flow cytometry, TACE surface levels were then monitored at each time point and recorded. U937 cells do not express endogenous L-selectin and so this could not be monitored. We can conclude from these findings that cantharidin (Can'din) induces increased surface expression of TACE, whereas PMA leads to a decrease in TACE expression. These results also highlight that TACE may be regulated differently between monocytes and lymphocytes. Figure S8 p38 MAPK affects both L-selectin shedding and TACE expression at the plasma membrane (A) LPS-induced shedding of L-selectin can be blocked by SB202190. Human monocytes were isolated from whole blood and challenged with 10 μg/ml LPS for 30 min at 37 • C. Flow cytometry was used to monitor remaining L-selectin on LPS-treated cells and relative expression levels were compared with monocytes treated with DMSO carrier for 30 min. (B) Relative expression levels of TACE and L-selectin (LAM) were measured on monocytes in response to challenge with 10 μg/ml of LPS over a 60 min period. These results further confirm that physiological activation of the p38 MAPK pathway promotes increased and sustained expression of TACE at the plasma membrane. Statistical significance was calculated using unpaired Student's t test; **P 0.01 and ***P 0.001. All experiments were performed at least three times in triplicate.
